跳转至内容
Merck
CN

SMB01325

阿苯达唑亚砜

≥97% (HPLC)

别名:

[5-(丙烷-1-亚磺酰基)-1H-苯并咪唑-2-基]-氨基甲酸甲酯, 氧阿苯达唑, 阿苯达唑亚砜

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C12H15N3O3S
化学文摘社编号:
分子量:
281.33
NACRES:
NA.77
UNSPSC Code:
12352119
Beilstein/REAXYS Number:
677664
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

阿苯达唑亚砜, ≥97% (HPLC)

Quality Level

SMILES string

CCCS(=O)c1ccc2[nH]c(NC(=O)OC)nc2c1

InChI

1S/C12H15N3O3S/c1-3-6-19(17)8-4-5-9-10(7-8)14-11(13-9)15-12(16)18-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)

InChI key

VXTGHWHFYNYFFV-UHFFFAOYSA-N

description

Modulation and Signaling

assay

≥97% (HPLC)

form

solid

color

white to beige

suitability

HPTLC

storage temp.

2-8°C

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

罗苯达唑是阿苯达唑的关键代谢产物,并作为驱虫药。研究表明,它可能通过使细胞周期停滞在 G2/M 期而诱导人癌细胞 HT-29 凋亡。

Application

Metabolomics research

General description

Albendazole sulfoxide is a blood-brain barrier main metabolite of anti-parasitic agent albendazole that acts as a antihelminthic. It binds to colchicine binding site of β-tubulin and prevents polymerization. Albendazole sulfoxide exhibits greater affinity to parasitic β-tubulin than to mammalian.

Other Notes

For additional information on our range of Biochemicals, please complete this form.

signalword

Warning

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - Skin Sens. 1 - STOT RE 2 Oral

target_organs

Adrenal gland,spleen,male reproductive organs,Blood

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lidia Radko et al.
Journal of veterinary research, 61(3), 313-319 (2018-07-07)
Albendazole is used to treat endoparasitic diseases in animals and humans. After oral administration, it is quickly oxidised into its pharmacologically active metabolite albendazole sulfoxide and then to sulfone. However, it is not clear which compound is responsible for toxic
Maximo Pettarin et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 155, 105552-105552 (2020-09-17)
The aim of this study was to use a combined in vitro-in silico approach to develop a physiologically based pharmacokinetic model (PBPK) that predicts the bioavailability of albendazole (ABZ), a BCS class II/IV lipophilic weak base, and simulates its main

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持